These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2910043)
1. Haemophilus B polysaccharide vaccine. Antibody kinetics in 17- to 71-month-old children. Ramsey KP; Popejoy LA; Jesse SW; Gonzales-Torres I Am J Dis Child; 1989 Jan; 143(1):28-30. PubMed ID: 2910043 [TBL] [Abstract][Full Text] [Related]
2. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Käyhty H; Karanko V; Peltola H; Mäkelä PH Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614 [TBL] [Abstract][Full Text] [Related]
3. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity. Adderson EE; Chisholm N; Halperin SA Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732 [TBL] [Abstract][Full Text] [Related]
4. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. Lucas AH; Azmi FH; Mink CM; Granoff DM J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants. Hendley JO; Wenzel JG; Ashe KM; Samuelson JS Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in 2- to 6-month-old infants. Lenoir AA; Granoff PD; Granoff DM Pediatrics; 1987 Aug; 80(2):283-7. PubMed ID: 3112729 [TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Peltola H; Käyhty H; Sivonen A; Mäkelä H Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children. Käyhty H; Peltola H; Eskola J Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853 [TBL] [Abstract][Full Text] [Related]
9. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine. Rubin LG; Voulalas D; Carmody L Pediatrics; 1989 Sep; 84(3):509-13. PubMed ID: 2788866 [TBL] [Abstract][Full Text] [Related]
10. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age]. Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652 [TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type B vaccine in children with sickle cell disease: antibody persistence after vaccination at age one and one-half to six years. Marcinak JF; Frank AL; Labotka RL; Rao S; Frisone LR; Yogev R; McVerry P Pediatr Infect Dis J; 1991 Feb; 10(2):157-9. PubMed ID: 2062609 [No Abstract] [Full Text] [Related]
12. [Vaccine against Haemophilus influenzae type b--antibody response and adverse effects]. Nøkleby H; Sandbu S; Käyhty H; Olander RM; Heilmann C Tidsskr Nor Laegeforen; 1995 May; 115(13):1604-6. PubMed ID: 7778073 [TBL] [Abstract][Full Text] [Related]
13. [Immunological principles of polysaccharide-protein conjugate vaccination]. Meyer M; Gahr M Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396 [TBL] [Abstract][Full Text] [Related]
14. [Vaccination of splenectomized children. Antibody response to Haemophilus influenzae type b conjugate vaccine]. Kristensen K Ugeskr Laeger; 1994 Jan; 156(2):191-3. PubMed ID: 8296410 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
16. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. Peltola H; Käyhty H; Virtanen M; Mäkelä PH N Engl J Med; 1984 Jun; 310(24):1561-6. PubMed ID: 6610125 [TBL] [Abstract][Full Text] [Related]
17. [Vaccine based on the capsular polysaccharide of Haemophilus influenzae type b]. Poolman JT; Rijkers GT Ned Tijdschr Geneeskd; 1988 Sep; 132(38):1737-40. PubMed ID: 3262833 [No Abstract] [Full Text] [Related]
18. Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. Spoulou V; Victoratos P; Ioannidis JP; Grafakos S J Infect Dis; 2000 Sep; 182(3):965-9. PubMed ID: 10950799 [TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249 [TBL] [Abstract][Full Text] [Related]
20. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]